IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
$10.28
+10.83% today · +21.86% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- IBRX +10.83% on the last session vs SPY +0.74%: +10.1 pts of stock-specific move.
- Aftermath, rsi overbought (Oct 2): After its 11 overbought readings in the past 5 years, IBRX typically lost 5.3% over the next month (median) and was higher only 45% of the time; half the outcomes fell between -16.9% and +32.6%. An ordinary month: -1.8%. Among S&P 500 stocks after overbought readings, that ranks #263 of 501.
- 0 Reddit mentions in the past 24 hours, 81% positive over the week · today's pace is 1.5× its recent daily average.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Insiders · 1 month
none
no open-market trades
Insiders · 3 months
none
no open-market trades
Congress · 3 months
none
no reported trades
Congress · 1 year
none
no reported trades
Insiders
| Trade date | Insider | Role | Side | Type | Shares | Avg price | Value | Filed |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Cheryl Cohen | Director | Sell | 10b5-1 plan | 131,210 | $9.50 | $1.2M | Jul 6 |
| Jul 1, 2026 | Christobel Selecky | Director | Sell | 10b5-1 plan | 159,478 | $9.02 | $1.4M | Jul 6 |
| Jun 30, 2026 | Christobel Selecky | Director | Sell | 10b5-1 plan | 96,722 | $9.01 | $871.2K | Jul 1 |
| Jun 24, 2026 | Barry J. Simon | Director | Sell | 10b5-1 plan | 25,000 | $7.88 | $196.9K | Jun 26 |
| Jun 4, 2026 | Barry J. Simon | Director | Sell | 10b5-1 plan | 23,033 | $7.18 | $165.3K | Jun 5 |
| Feb 24, 2026 | Barry J. Simon | Director | Sell | 10b5-1 plan | 75,000 | $12.01 | $900.8K | Feb 26 |
| Feb 23, 2026 | Barry J. Simon | Director | Sell | 10b5-1 plan | 175,000 | $10.19 | $1.8M | Feb 24 |
| Feb 23, 2026 | Christobel Selecky | Director | Sell | 10b5-1 plan | 25,000 | $10.00 | $250K | Feb 24 |
| Feb 22, 2026 | Barry J. Simon | Director | Tax | tax withholding | 6,026 | $8.70 | $52.4K | Feb 24 |
| Feb 22, 2026 | Richard Adcock | CEO | Tax | tax withholding | 77,560 | $8.70 | $674.8K | Feb 24 |
| Feb 22, 2026 | Regan J Lauer | CAO | Tax | tax withholding | 1,673 | $8.70 | $14.6K | Feb 24 |
| Feb 22, 2026 | Patrick Soon-shiong | Director | Tax | tax withholding | 58,170 | $8.70 | $506.1K | Feb 24 |
| Feb 22, 2026 | David C. Sachs | CFO | Tax | tax withholding | 20,682 | $8.70 | $179.9K | Feb 24 |
| Feb 10, 2026 | Richard Adcock | CEO | Tax | tax withholding | 140,048 | $6.93 | $970.5K | Feb 12 |
| Feb 10, 2026 | Regan J Lauer | CAO | Tax | tax withholding | 2,257 | $6.93 | $15.6K | Feb 12 |
| Feb 10, 2026 | David C. Sachs | CFO | Tax | tax withholding | 42,643 | $6.93 | $295.5K | Feb 12 |
| Feb 10, 2026 | Patrick Soon-shiong | Director | Tax | tax withholding | 118,560 | $6.93 | $821.6K | Feb 12 |
| Jan 20, 2026 | Christobel Selecky | Director | Sell | 10b5-1 plan | 75,000 | $5.84 | $437.6K | Jan 21 |
| Jan 20, 2026 | Barry J. Simon | Director | Sell | 10b5-1 plan | 151,967 | $7.20 | $1.1M | Jan 21 |
| Dec 31, 2025 | Richard Adcock | CEO | Tax | tax withholding | 17,510 | $1.98 | $34.7K | Jan 5 |
| Dec 31, 2025 | David C. Sachs | CFO | Tax | tax withholding | 15,435 | $1.98 | $30.6K | Jan 5 |
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
No congressional trades in IBRX on record.
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily. All recent insider and congressional trades